Pfizer expands access to the Covid pill.
Following the path already taken by Merck, the pharmaceutical giant signs a licensing agreement with the UN-backed Medicines Patent Pool to expand access to its antiviral pill in developing countries.
Agreement to increase supplies of Pfizer's anti-viral pills.
In fact, generic drug manufacturers will be able to produce the drug in advance of the authorities' green light to speed up supplies to low- and middle-income countries.
The agreement is the first with which the company opens to the sharing of technology on an anti Covid product.